.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Colorcon
UBS
Dow
Citi
Medtronic
Cipla
Cantor Fitzgerald
Express Scripts
Baxter

Generated: December 15, 2017

DrugPatentWatch Database Preview

CHILDREN'S ZYRTEC ALLERGY Drug Profile

« Back to Dashboard

When do Children's Zyrtec Allergy patents expire, and when can generic versions of Children's Zyrtec Allergy launch?

Children's Zyrtec Allergy is a drug marketed by J And J Consumer Inc and is included in two NDAs. There is one patent protecting this drug.

This drug has twenty-five patent family members in twenty countries and two supplementary protection certificates in two countries.

The generic ingredient in CHILDREN'S ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Drug patent expirations by year for CHILDREN'S ZYRTEC ALLERGY

Medical Subject Heading (MeSH) Categories for CHILDREN'S ZYRTEC ALLERGY

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer IncCHILDREN'S ZYRTEC ALLERGYcetirizine hydrochlorideSYRUP;ORAL022155-002Nov 16, 2007OTCYesYes► Subscribe► Subscribe► Subscribe
J And J Consumer IncCHILDREN'S ZYRTEC ALLERGYcetirizine hydrochlorideTABLET, CHEWABLE;ORAL021621-003Nov 16, 2007DISCNYesNo► Subscribe► SubscribeY► Subscribe
J And J Consumer IncCHILDREN'S ZYRTEC ALLERGYcetirizine hydrochlorideTABLET, CHEWABLE;ORAL021621-004Nov 16, 2007DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CHILDREN'S ZYRTEC ALLERGY

Country Document Number Estimated Expiration
Australia727140► Subscribe
European Patent Office0994710► Subscribe
South Korea20010014398► Subscribe
Belgium1011251► Subscribe
Australia8201598► Subscribe
Israel133397► Subscribe
Brazil9810495► Subscribe
Hong Kong1029060► Subscribe
Poland192348► Subscribe
Russian Federation2192863► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CHILDREN'S ZYRTEC ALLERGY

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
01C/045Belgium► SubscribePRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
00085Netherlands► SubscribePRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
US Army
UBS
Argus Health
Boehringer Ingelheim
Deloitte
Colorcon
QuintilesIMS
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot